ORTEXORTEX News
Tracking PCG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PC
Trader NotePCG

PG&E Lags Peers as Call Skew Hits an Extreme

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 18:52

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

PG&E Corporation carries one of the least-shorted profiles in the electric utility peer group heading into Thursday's third-quarter earnings release, yet its shares have moved in the wrong direction relative to almost everyone else on the board this week.

Among its closest peers, EIX added 1.9% over the past week, XEL gained 2.7%, and DUK rose 2.7%. PCG fell 1.1% over the same period, closing Tuesday at $13.18. The divergence is striking because short interest gives no obvious explanation for the underperformance. At 1.42% of free float, PCG's short position is low by almost any measure. It has been falling hard over the past month, down roughly 23% since late September, when it briefly touched above 40 million shares. The borrow market reinforces that picture: the cost to borrow collapsed to 0.14% on Tuesday, less than a third of where it was a week ago. Availability is essentially unlimited at 8,559%, meaning the lending pool holds roughly 2.2 billion shares ready to lend against a short position of just 31 million. There is no structural short pressure here.

Options positioning tells a more charged story. Call demand has been exceptionally heavy, pushing the put-call ratio to 0.11, nearly two standard deviations below its 20-day average of 0.16. That is the lowest reading in 52 weeks and sits just above the all-time low of 0.11 recorded Monday. Options traders are positioned for a materially better outcome than the share price trajectory suggests, a tension that the Q3 print will either resolve or sharpen.

The Street has been adjusting its sights lower. Morgan Stanley raised its target to $21 this morning while holding Equal-Weight, the first upward revision in weeks. Before that, the flow had been one-directional: Barclays and JP Morgan both trimmed to $17 in mid-October, UBS downgraded to Neutral and cut to $14 in late September, and Truist moved to Hold in early September. The mean consensus target remains at $18.56, a 41% premium to the current price. At a price-to-earnings of 7.4x and price-to-book of 0.77x, the valuation is cheap on paper. Factor scores put the dividend rank at the 86th percentile and the short score rank at 81st, both reflecting the low short position and the income profile. EPS momentum and surprise scores are more muted, sitting near the 48th to 52nd percentile range.

Retail attention has picked up sharply into the print. Wikipedia views and ORTEX stock page traffic are running 3.81 standard deviations above their 90-day norm, a notable spike for a utility that rarely generates much retail interest. The EPA's Clean Air Markets program data shows PCG's gross capacity factor at its lowest reading since the series began in 2024, hitting 5.12% in June. That dataset has not been tested as a lead indicator for the company's reported figures, so it is colour rather than signal, but the operating picture it reflects is worth noting.

The one number that would shift the overall picture is whether the Q3 print changes the trajectory of analyst revisions. The gap between the $13.18 price and the $18.56 mean target is wide enough that even a modest reset in either direction would carry weight. The earnings release on October 22 is the next hard data point.

Stocks in this article

See the live data behind this article on ORTEX.

Open PCG on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:53
Data as of
21 Oct 2026, 18:52
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.